Emyria Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Emyria.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 47.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Will Emyria (ASX:EMD) Spend Its Cash Wisely?
Feb 02We're Hopeful That Emyria (ASX:EMD) Will Use Its Cash Wisely
May 20Here's Why We're Not Too Worried About Emyria's (ASX:EMD) Cash Burn Situation
Oct 20We Think Emyria (ASX:EMD) Needs To Drive Business Growth Carefully
Jun 11Will Emyria (ASX:EMD) Spend Its Cash Wisely?
Feb 25Need To Know: Emyria Limited (ASX:EMD) Insiders Have Been Buying Shares
Nov 17In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Emyria has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 2 | -11 | -6 | -4 | N/A |
3/31/2024 | 2 | -12 | -6 | -5 | N/A |
12/31/2023 | 2 | -12 | -7 | -5 | N/A |
9/30/2023 | 2 | -9 | -7 | -4 | N/A |
6/30/2023 | 2 | -5 | -7 | -4 | N/A |
3/31/2023 | 2 | -6 | -8 | -5 | N/A |
12/31/2022 | 2 | -8 | -9 | -6 | N/A |
9/30/2022 | 2 | -7 | -8 | -6 | N/A |
6/30/2022 | 2 | -7 | -7 | -5 | N/A |
3/31/2022 | 2 | -7 | N/A | N/A | N/A |
12/31/2021 | 2 | -6 | -6 | -4 | N/A |
9/30/2021 | 2 | -6 | -5 | -4 | N/A |
6/30/2021 | 2 | -5 | -5 | -4 | N/A |
3/31/2021 | 2 | -5 | N/A | N/A | N/A |
12/31/2020 | 2 | -5 | -5 | -4 | N/A |
9/30/2020 | 1 | -5 | -5 | -4 | N/A |
6/30/2020 | 1 | -5 | -5 | -4 | N/A |
3/31/2020 | 1 | -5 | -4 | -4 | N/A |
12/31/2019 | 1 | -4 | -3 | -3 | N/A |
9/30/2019 | 0 | -3 | -3 | -3 | N/A |
6/30/2019 | 0 | -3 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if EMD's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if EMD's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if EMD's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if EMD's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if EMD's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EMD's Return on Equity is forecast to be high in 3 years time